These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22879845)

  • 1. Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.
    Oleniuc M; Secara I; Onofriescu M; Hogas S; Voroneanu L; Siriopol D; Covic A
    Maedica (Bucur); 2011 Oct; 6(4):298-307. PubMed ID: 22879845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
    Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products in renal failure: an overview.
    Noordzij MJ; Lefrandt JD; Smit AJ
    J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review.
    Arsov S; Graaff R; van Oeveren W; Stegmayr B; Sikole A; Rakhorst G; Smit AJ
    Clin Chem Lab Med; 2014 Jan; 52(1):11-20. PubMed ID: 23612551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis.
    Cavero-Redondo I; Soriano-Cano A; Álvarez-Bueno C; Cunha PG; Martínez-Hortelano JA; Garrido-Miguel M; Berlanga-Macías C; Martínez-Vizcaíno V
    J Am Heart Assoc; 2018 Sep; 7(18):e009833. PubMed ID: 30371199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.
    Hartog JW; de Vries AP; Bakker SJ; Graaff R; van Son WJ; van der Heide JJ; Gans RO; Wolffenbuttel BH; de Jong PE; Smit AJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2263-9. PubMed ID: 16597636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
    Yamagishi S; Fukami K; Matsui T
    Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.
    Da Moura Semedo C; Webb M; Waller H; Khunti K; Davies M
    Postgrad Med J; 2017 May; 93(1099):289-294. PubMed ID: 28143896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
    Smit AJ; Gerrits EG
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):527-33. PubMed ID: 20844429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
    Fokkens BT; Smit AJ
    Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
    Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
    Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple noninvasive measurement of skin autofluorescence.
    Meerwaldt R; Links T; Graaff R; Thorpe SR; Baynes JW; Hartog J; Gans R; Smit A
    Ann N Y Acad Sci; 2005 Jun; 1043():290-8. PubMed ID: 16037251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.
    Ueno H; Koyama H; Tanaka S; Fukumoto S; Shinohara K; Shoji T; Emoto M; Tahara H; Kakiya R; Tabata T; Miyata T; Nishizawa Y
    Metabolism; 2008 Oct; 57(10):1452-7. PubMed ID: 18803952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.
    Simon Klenovics K; Kollárová R; Hodosy J; Celec P; Sebeková K
    Diabet Med; 2014 May; 31(5):581-5. PubMed ID: 24111899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.